How do the ancient traditions shed light on the interplay between science, spirituality, and the transformative journey of self-discovery? In this episode, Dr. Dave Rabin and Katie Silcox explore the fascinating intersection of science and spirituality. Katie, with an extensive background in Hinduism and Ayurveda, shares her journey into the world of tantric and yogic traditions. They discuss how these traditions aim to expand the mind beyond our limitations, emphasizing practices like breathing for inner exploration. The conversation touches on how these practices actually change our bodies, including Kundalini awakening and the balance of inner feminine and masculine aspects. They also explore the importance of grounding, self-acceptance, and the rise of the divine feminine in modern spirituality. Overall, this episode continues our 2024 exploration into the intricate connections between science and spirituality, providing a holistic understanding of consciousness and the deep interplay between mind, body, and ancient wisdom.Web: https://theshaktischool.com/Instagram: https://www.instagram.com/theshaktischool/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com

How do you define sobriety?This week's episode features an enlightening discussion with biohacking influencer and interviewer Luke Storey about his personal journey with addiction, recovery, and the mindful integration of plant medicines.Luke shares vulnerably about the childhood trauma that led him down a path of substance abuse, and how eventually hitting rock bottom inspired his sobriety 24 years ago.He explained his thoughtful process around redefining sobriety and abstinence as he began to explore the healing potential of psychedelics like ayahuasca.Luke and Dr. Dave Rabin have an insightful conversation about the difference between substances that disconnect us from consciousness versus those that can open portals to personal and spiritual growth.They explored the importance of set, setting, intention, and integration when working with plant medicines. Join us for this thought-provoking look at how psychedelic medicines, when used consciously, can catalyze awe, disrupt negative thought patterns, reveal deeper layers of healing, and may provide a glimmer of hope for addiction treatment in the 21st century.Web: https://www.lukestorey.com/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/

Join us for a thoughtful conversation between expert panelists in the fields of psychology, neuroscience, meditation, and psychedelics, recorded live at Open studio in Venice, California. Led by Apollo Neuro co-founder and Chief Medical Officer Dr. Dave Rabin, MD, PhD, with Manoj Dias, co-founder of Open, and Lauren Swanson, the Director of Patient Care at Wondermed Health, which provides ketamine treatment for anxiety and depression, they discuss where mindful practices like meditation and breathwork, psychedelic medicine, and wearable health overlap and where they differ, and how these practices can be used in tandem for healing and growth.Learn more about Apollo Neuro here.Download Open's mindfulness app here.Discover more about Wondermed here.

Is the field of psychedelic therapy receiving the educational support it needs? In this episode, Dr. Dave Rabin engages in a thought-provoking conversation with Dr. Allison Feduccia, a neuropharmacologist and the founder of Psychedelic Support. They explore the organization's mission, which includes providing crucial resources, a directory of licensed health professionals, and ACCME-accredited online courses covering substances like MDMA, psilocybin, and ketamine. The episode sheds light on the hurdles Psychedelic Support faces in obtaining ACCME accreditation for their courses, raising concerns about the impact on education accessibility. The dialogue encompasses the FDA's warning on ketamine treatments, its contradictory extension through telehealth by the DEA, and Dr. Allison Feduccia's personal journey with ayahuasca, leading to her involvement in equine facilitated services and the development of a course on equine therapy. As they discuss the potential changes in accreditation, Dr. Allison emphasizes the significance of clinicians taking these courses and supporting organizations like Psychedelic Support in advancing psychedelic therapy education.Web: https://psychedelic.support/ACCME Web:https://www.accme.org/https://www.instagram.com/accreditedcmeContact number: (312) 527-9200Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/

Have you ever wondered about the real-world impact of microdosing psychedelics? In this episode, Dr. Dave Rabin interviews Dr. Pamela Kryskow and Dr. Zach Walsh, investigators on the Microdose.me study—one of the world's largest real-world studies on people microdosing psychedelics. Dr. Kryskow and Dr. Walsh discuss their backgrounds and entry into the psychedelic space, emphasizing the importance of observing real-world experiences. The Microdose.me study aims to provide substantial clinical data to support this promising new area of research. Their findings highlight positive outcomes for microdosers, including cognitive benefits for individuals over 55. The researchers stress the challenges of real-world studies, the need for collaboration, and the study's potential to guide future clinical trials.Web: Microdose.meTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/

In this episode Dr. Dave Rabin had the privilege of speaking with the late Dr. Roland Griffiths, a renowned figure in the field of psychedelic science and medicine. Dr. Griffiths, who passed away on October 16, 2023, was a pioneer in the study of consciousness and the therapeutic potential of psychedelic medicines. Dr. Griffiths was the Director of the Center for Psychedelic and Consciousness Research at Johns Hopkins University School of Medicine, shares his journey into the field, driven by his interest in meditation and altered states of consciousness. His groundbreaking research on psilocybin, the active compound in magic mushrooms, is discussed, highlighting the profound effects it induces, including mystical experiences and psychological insights. Dr. Griffiths underscores the need for further research into the variations among different strains of psilocybin mushrooms and the future of psychedelic therapy, which may involve novel compounds and therapeutic approaches. This episode provides valuable insights into the potential of psilocybin mushrooms for depression treatment and the ongoing advancements in psychedelic medicine.Web: https://hopkinspsychedelic.org/griffithsTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/

What is the Mind-Body Connection? In this episode, Dr. Candace Lewis PhD guides us through the intriguing intersections of stress, trauma, epigenetics, and mental health. Beginning her research in an addiction lab, she explored early-life stress and its impact on addiction vulnerability. Her deepening interest in epigenetics led her to delve into how traumatic experiences can alter gene regulation in the brain, laying the foundation for her exploration of psychedelics and their potential for healing. Candice stresses the importance of distinguishing between drug classes, with a focus on the therapeutic potential of psychedelics that can induce positive behavioral changes. Her pivotal research includes a pilot study on MDMA-assisted therapy for PTSD, suggesting DNA methylation changes may contribute to treatment responses. The conversation extends to redefining trauma, the role of genetics and epigenetics in mental health, and the intriguing link between psychology, the brain, and the body. Candice also highlights ongoing studies on psychedelics, cognitive abilities and epigenetics, offering hope for cognitive decline prevention. Her lab initiatives encompass a social media drug education project and the Translational Research in Psychedelics (TRIP) team, both aimed at raising awareness and fostering informed discussions.https://TheBearLab.org/@the_bear_labYour Brain Explained

Have you ever wondered how you can make a difference in the betterment of mental health care for all? In this episode, Dr. Dave Rabin gets the latest updates from Dr. Jeanne Fontana MD, PhD about the Treat California campaign, a citizen-driven ballot initiative to revolutionize the way we deliver mental healthcare in the US by allocating over $5 billion to improving research, training, and safe access to psychedelic therapies. Today, we call on all Californians to show that you care about solving the crisis of mental illness up by donating $10, signing a petition, and educating others to do the same. Dr. Fontana's dream is to make these life-changing medicines accessible to every American and her team is well on the way! Dr. Fontana also reminds us of the importance of patience and compassion as we strive for better mental health care. Could this campaign be as game-changing as supporting the discovery of antibiotics were for infections? Tune in to find out and learn how you can play a critical role in making high quality mental health care available for all by joining the TreatCalifornia movement.www.TreatCalifornia.orghttps://voterstatus.sos.ca.gov/https://registertovote.ca.gov/@treatcalifornia

Can investing in psychedelics pave the way for a more conscious and compassionate approach to mental health and wellness? Dr. David Rabin engages in an illuminating conversation with Ozan Polat and Ryan Zurrer, a trailblazing venture capitalist redefining investment paradigms in the psychedelic space. Ryan introduces the concept of regenerative financing, sharing an innovative hybrid model that combines equity and debt for organizations like MAPS, fostering conscious health and sustainable investments. This episode delves into the balance between impact and profit, emphasizing the importance of cultural respect and responsible capital deployment. The trio dig into the imperative of respectful engagement with indigenous traditions and knowledge, highlighting the need for sustainable and non-extractive collaboration, the promising trajectory of psychedelic therapies, their increasing accessibility, and the potential to revolutionize mental health. Excitement resonates as they envision a future where acceptance of these therapies is widespread, even among generations who have been skeptical. Gratitude permeates as they reflect on the significance of building awareness and a strong scientific foundation for this transformative industry.https://www.vine.vc/

What if ancient medicines held the key to profound healing and transformation? In this enlightening episode of "The Psychedelic Report," Dr. Dave Rabin engages in a captivating conversation with Dr. Joseph Barsuglia, an esteemed clinical psychologist and MAPS-trained MDMA-assisted psychotherapist. Together, they delve into the depths of Iboga and 5MEO-DMT – two potent substances with rich histories and remarkable potentials. Explore the cultural heritage of Iboga in the Bwiti tradition, its therapeutic applications, and the delicate balance of its conservation. Uncover the mysteries of 5MEO-DMT, its unique effects, and the necessity of proper guidance. Join them in unraveling the transformative power of these ancient medicines and the responsible paths to harnessing their benefits within the realms of spirituality and therapy.